Effect of soy isoflavones on endometriosis: Interaction with estrogen receptor 2 gene polymorphism

Epidemiology

Volumn 18, Issue 3, 2007, Pages 402-408

  Tsuchiya, Masaki ^a,c   Miura, Tsutomu ^a   Hanaoka, Tomoyuki ^a   Iwasaki, Motoki ^a   Sasaki, Hiroshi ^b   Tanaka, Tadao ^b   Nakao, Hiroyuki ^c   Katoh, Takahiko ^c   Ikenoue, Tsuyomu ^c   Kabuto, Michinori ^d   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR 2; GENISTEIN; ISOFLAVONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG BLOOD LEVEL; DRUG DETERMINATION; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR GENE; RISK REDUCTION; SOYBEAN; URINE LEVEL;

ADULT; DIET; ENDOMETRIOSIS; ESTROGEN RECEPTOR BETA; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK; SOYBEANS;

EID: 34247191313     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000257571.01358.f9     Document Type: Article

References (31)

1. Tham DM, Gardner CD, Haskell WL. Clinical review 97: potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab. 1998;83:2223-2235.
2. Wagner JD, Anthony MS, Cline JM. Soy phytoestrogens: research on benefits and risks. Clin Obstet Gynecol. 2001;44:843-852.
3. Gruber CJ, Tschugguel W, Schneeberger C, et al. Production and actions of estrogens. N Engl J Med. 2002;346:340-352.
4. Limer JL, Speirs V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res. 2004;6:119-127.
5. Yamamoto S, Sobue T, Kobayashi M, et al. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst. 2003;95:906-913.
6. Grace PB, Taylor JI, Low YL, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomarkers Prev. 2004;13:698-708.
7. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006;98:459-471.
8. Kennedy S. The genetics of endometriosis. J Reprod Med. 1998;43:263-268.
9. Cramer DW, Missmer SA. The epidemiology of endometriosis. Ann NY Acad Sci. 2002;955:11-22.
10. Vigano P, Parazzini F, Somigliana E, et al. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004;18:177-200.
11. Georgiou I, Syrrou M, Bouba I, et al. Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril. 1999;72:164-166.
12. Kitawaki J, Obayashi H, Ishihara H, et al. Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod. 2001;16:51-55.
13. Wang Z, Yoshida S, Negoro K, et al. Polymorphisms in the estrogen receptor beta gene but not estrogen receptor alpha gene affect the risk of developing endometriosis in a Japanese population. Fertil Steril. 2004;81:1650-1656.
14. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139:4252-4263.
15. Tsukino H, Hanaoka T, Sasaki H, et al. Associations between serum levels of selected organochlorine compounds and endometriosis in infertile Japanese women. Environ Res. 2005;99:118-125.
16. American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril. 1985;43:351-352.
17. Marchino GL, Gennarelli G, Enria R, et al. Diagnosis of pelvic endometriosis with use of macroscopic versus histologic findings. Fertil Steril. 2005;84:12-15.
18. Zondervan KT, Cardon LR, Kennedy SH. What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod. 2002;17:1415-1423.
19. Maskarinec G, Singh S, Meng L, et al. Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev. 1998;7:613-619.
20. Arai Y, Uehara M, Sato Y, et al. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol. 2000;10:127-135.
21. Yamamoto S, Sobue T, Sasaki S, et al. Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr. 2001;131:2741-2747.
22. Gamache PH, Acworth IN. Analysis of phytoestrogens and polyphenols in plasma, tissue, and urine using HPLC with coulometric array detection. Proc Soc Exp Biol Med. 1998;217:274-280.
23. Sundarrajan C, Liao WX, Roy AC, et al. Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab. 2001;86:135-139.
24. Wang TT, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis. 1996;17:271-275.
25. Manach C, Williamson G, Morand C, et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005;81(1 Suppl):230S-242S.
26. King RA, Bursill DB. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr. 1998;67:867-872.
27. Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood). 2005;230:155-170.
28. Lecce G, Meduri G, Ancelin M, et al. Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metab. 2001;86:1379-1386.
29. Shen LX, Basilion JP, Stanton VP Jr. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci USA. 1999;96:7871-876.
30. Missmer SA, Hankinson SE, Spiegelman D, et al. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol. 2004;104:965-974.
31. Missmer SA, Hankinson SE, Spiegelman D, et al. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol. 2004;160:784-796.